OBJECTIVE: This study was conducted to identify the predictors of mortality and to evaluate the impact of methicillin resistance on outcome in patients with Staphylococcus aureus infection according to underlying conditions and type of infection. METHODS: An observational cohort study including 4949 patients with S. aureus infection was conducted. We compared data from patients with MRSA infection with those with MSSA infection. RESULTS: The 30-day mortality rate of MRSA group was significantly higher than that of MSSA group (15.6% vs. 6.2%, P < 0.001). However, MRSA infection was not found to be independent risk factor for mortality after adjusting for other variables (OR = 1.03, 95% CI = 0.80-1.32). When we analyzed patients with S. aureus bacteremia (n = 709), MRSA infection was found to be significantly associated with mortality in multivariate analysis (Adjusted OR = 1.69, 95% CI = 1.15-2.49). When the 30-day mortality rates were compared according to underlying diseases, the 30-day mortality rate of MRSA group was significantly higher than that of MSSA group in patients with malignancy or renal diseases. MRSA infection was also found to be one of the independent risk factors for mortality in patients with malignancy (adjusted OR = 1.69, 95% CI = 1.06-2.70) and in those with renal disease (adjusted OR = 1.70, 95% CI = 1.0-2.89), after adjustment for host variables. CONCLUSIONS: Methicillin resistance adversely affected the outcome of patients with S. aureus infection, in patients with cancer or renal disease and in those with S. aureus bacteremia, although MRSA infection was not found to be significantly associated with higher mortality in overall patient population.
OBJECTIVE: This study was conducted to identify the predictors of mortality and to evaluate the impact of methicillin resistance on outcome in patients with Staphylococcus aureus infection according to underlying conditions and type of infection. METHODS: An observational cohort study including 4949 patients with S. aureus infection was conducted. We compared data from patients with MRSA infection with those with MSSA infection. RESULTS: The 30-day mortality rate of MRSA group was significantly higher than that of MSSA group (15.6% vs. 6.2%, P < 0.001). However, MRSA infection was not found to be independent risk factor for mortality after adjusting for other variables (OR = 1.03, 95% CI = 0.80-1.32). When we analyzed patients with S. aureus bacteremia (n = 709), MRSA infection was found to be significantly associated with mortality in multivariate analysis (Adjusted OR = 1.69, 95% CI = 1.15-2.49). When the 30-day mortality rates were compared according to underlying diseases, the 30-day mortality rate of MRSA group was significantly higher than that of MSSA group in patients with malignancy or renal diseases. MRSA infection was also found to be one of the independent risk factors for mortality in patients with malignancy (adjusted OR = 1.69, 95% CI = 1.06-2.70) and in those with renal disease (adjusted OR = 1.70, 95% CI = 1.0-2.89), after adjustment for host variables. CONCLUSIONS:Methicillin resistance adversely affected the outcome of patients with S. aureus infection, in patients with cancer or renal disease and in those with S. aureus bacteremia, although MRSA infection was not found to be significantly associated with higher mortality in overall patient population.
Authors: S McNicholas; A Fe Talento; J O'Gorman; M M Hannan; M Lynch; C M Greene; P J Conlon; A C Shore; D C Coleman; H Humphreys; D Fitzgerald-Hughes Journal: Eur J Clin Microbiol Infect Dis Date: 2016-09-09 Impact factor: 3.267
Authors: G E Park; J-H Ko; S Y Cho; Y E Ha; N Y Lee; C-I Kang; D R Chung; J-H Song; K R Peck Journal: Eur J Clin Microbiol Infect Dis Date: 2017-01-11 Impact factor: 3.267
Authors: Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell Journal: Clin Microbiol Rev Date: 2012-04 Impact factor: 26.132
Authors: S Pollett; S M Baxi; G W Rutherford; S B Doernberg; P Bacchetti; H F Chambers Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191
Authors: Carlos Seas; Coralith Garcia; Mauro J Salles; Jaime Labarca; Carlos Luna; Carlos Alvarez-Moreno; Carlos Mejía-Villatoro; Jeannete Zurita; Manuel Guzmán-Blanco; Eduardo Rodríguez-Noriega; Jinnethe Reyes; Cesar A Arias; Cesar Carcamo; Eduardo Gotuzzo Journal: J Antimicrob Chemother Date: 2018-01-01 Impact factor: 5.790
Authors: Susan S Huang; Rupak Datta; Sheryl Rifas-Shiman; Ken Kleinman; Hilary Placzek; Julie D Lankiewicz; Richard Platt Journal: Crit Care Date: 2011-09-14 Impact factor: 9.097
Authors: Hea Sung Ok; Hyoun Soo Lee; Man Je Park; Ki Hoon Kim; Byeong Ki Kim; Yu Mi Wi; June Myung Kim Journal: Korean J Intern Med Date: 2013-10-29 Impact factor: 2.884